Infusion Clinical Trials

33 recruitingLast updated: July 25, 2026

There are 33 actively recruiting infusion clinical trials across 13 countries. Studies span Not Applicable, Phase 2, Phase 4, Early Phase 1. Top locations include Cairo, Egypt, Tucson, Arizona, United States, Milwaukee, Wisconsin, United States. Updated daily from ClinicalTrials.gov.


Infusion Trials at a Glance

33 actively recruiting trials for infusion are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Cairo, Tucson, and Milwaukee. Lead sponsors running infusion studies include Ain Shams University, Nanfang Hospital, Southern Medical University, and Tanta University.

Browse infusion trials by phase

Treatments under study

About Infusion Clinical Trials

Looking for clinical trials for Infusion? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infusion trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infusion clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting
Phase 4

Paracervical Block for Pain Reduction in Saline Infusion Sonograms

Pain During Saline Infusion Sonogram
Montefiore Medical Center246 enrolled1 locationNCT07048769
Recruiting
Early Phase 1

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

LymphomaLeukemiaCAR-T Cell Therapy+3 more
University of Arizona200 enrolled1 locationNCT06643221
Recruiting

Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider

Spinal fusion surgeryTotal Intravenous AnesthesiaAnesthesia Depth Monitoring+2 more
Istanbul University50 enrolled1 locationNCT07586189
Recruiting
Not Applicable

Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure

Neonatal Brain Injuryperinatal morbidityMechanical Ventilation+10 more
Medical College of Wisconsin320 enrolled1 locationNCT07274527
Recruiting
Phase 2

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Hepatocellular CarcinomaRadiotherapyImmunotherapy+3 more
Shandong Cancer Hospital and Institute54 enrolled1 locationNCT07062055
Recruiting
Not Applicable

Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage

Critical IllnessSubarachnoid HemorrhageInfusion Fluid+1 more
Insel Gruppe AG, University Hospital Bern320 enrolled3 locationsNCT04043598
Recruiting

Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Series.

Chronic PainOutpatientLidocaine Infusion+1 more
Medical University of Warsaw500 enrolled1 locationNCT07555314
Recruiting
Phase 4

Perioperative Use of Erector Spinae Plane Block (ESPB) and Intravenous Lidocaine Infusion in Anesthetic Management of Spinal Surgery in Children

Regional AnesthesiaLidocaine Infusion
Saint Petersburg State University, Russia68 enrolled1 locationNCT06965933
Recruiting
Phase 2

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

Infusion Reactions
New York Blood Center9,999 enrolled71 locationsNCT01656603
Recruiting
Phase 4

Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie

OncologyInfusion Reaction
Isala776 enrolled1 locationNCT06031233
Recruiting

AI-Assisted Analgesia Copilot System

Artificial Intelligence (AI)NociceptionTarget Controlled Infusion (TCI)+1 more
Pontificia Universidad Catolica de Chile150 enrolled2 locationsNCT07253012
Recruiting
Phase 2

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Pain ManagementSickle Cell DiseaseVaso-Occlusive Crises+2 more
Mohsen Saidinejad120 enrolled1 locationNCT07369024
Recruiting

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

Targeted TherapyImmunotherapyHepatocellular Carcinoma (HCC)+2 more
Nanfang Hospital, Southern Medical University90 enrolled1 locationNCT07436845
Recruiting
Phase 2

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

BevacizumabHepatecellular CarcinomaRALOX-HAIC(Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin+3 more
Nanfang Hospital, Southern Medical University38 enrolled1 locationNCT07327788
Recruiting
Phase 2

Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy

Hepatic Artery InfusionLiver Metastasis of Breast Cancer
Zhejiang Cancer Hospital30 enrolled1 locationNCT07284836
Recruiting

A Comparative Study of Eleveld and Schnider Pharmacokinetic Models for Target-Controlled Infusion of Propofol in Sedation of Mechanically Ventilated ICU Patients

SedationIntensive Care Unit SedationTarget Controlled Infusion of Propofol
Hacettepe University84 enrolled1 locationNCT07239687
Recruiting

Intraosseous Infusion in Hematologic Critical Patients

Intraosseous Infusions
Shanxi Bethune Hospital52 enrolled1 locationNCT07239375
Recruiting
Not Applicable

Validation of the Effectiveness of the CFIR - ERIC Matching Tool in Implementation Research

Implementation ScienceInfusions, Intravenous
Children's Hospital of Fudan University394 enrolled1 locationNCT07184489
Recruiting
Not Applicable

Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience

Central Venous CathetersVascular access devicesPatient Participation+20 more
Fundacion Miguel Servet201 enrolled1 locationNCT06905119
Recruiting
Not Applicable

Intraoperative Infusion of Either Lidocaine or Dexmedetomidine on Regional Cerebral Oxygen Saturation and Postoperative Delirium in Elderly Patients Undergoing Abdominal Surgeries

Cerebral oxygen saturationDexmedetomidineElderly Patients+4 more
Tanta University100 enrolled1 locationNCT07108764